BCR and chronic myelogenous leukemia, BCR-ABL1 positive: For example, ABL1 was selectively activated in the Chronic myeloid leukemia (CML) cell line SPI-801, which was consistent with BCR-ABL1–driven signaling and imatinib sensitivity.27